SIXTH INTERNATIONAL IMMUNOLOGY SUMMITOptimizing management of
musculoskeletal diseases:
treating the human and the being
Chair: Peter Taylor
Prague, 1214 March 2015
First announcement
This educational event is organized by UCB
All attendees will have the opportunity to participate in a
number of mini-symposia. All workshops will be facilitated by
expert faculty. Further information about these sessions and how to
register for your preferred option will be available on our
upcoming website.
Topics will include Patient communication workshop: how can your
patient help you treat their
disease better?
Pain and the brain: how neuroscience neurobiology helps us deal
better with rheumatic disease
Therapeutic drug monitoring strategies
Managing co-morbidities in rheumatic diseases: the impact of
peripheral inflammation on body and mind
Detecting depression and anxiety disorders in rheumatic
diseases: practical tips, everyday solutions
Interpreting MRI in AxSpA
Challenging cases in AxSpA: right patient, right treatment
Diagnosis and monitoring of AxSpA in the clinic
Beyond evidence-based medicine: what have we learned about
biologic therapies in observational studies?
Difficult cases in rheumatology: RA and PsA
Use of musculoskeletal ultrasound in rheumatic disease: RA and
PsA
Diagnosis and management of PsA: a shared responsibility between
disciplines
How do we manage pregnancy in women suffering from
RA/AxSpA/PsA?
Clinical care of vasculitis
Programme may be subject to change
Planned mini-symposia sessions
IMNL-EDU-001004
Right page (Folds in under front page)146 mm
Back page!48 mm
Front page148 mm
210mm
CIM14711214
U047868Text BoxCIM0870115CER0940115
Throughout the Summit, there will be opportunities to
participate in a number of mini-symposia.
Summit Open
Session chairPeter TaylorFacultyMaxime Dougados Karel Pavelka
Jiri Vencovsky
Welcome reception and Summit introduction
Beyond treat-to-target: a holistic approach to treatment of
rheumatic diseases
Session chairPeter TaylorFacultyRakesh Jain Laure Gossec
Putting patients at the heart of care: changing needs in the
face of evolving therapies
Treating the mind and the body: an integrated approach to
chronic pain
Patient-reported outcomes: their views can help us improve their
wellbeing
Improving the patient experience in SLE
Session chairThomas DrnerFacultyIan Bruce Susan Manzi
B cell biology in the SLE disease course: why this matters
Practical guidance on treatment goals in SLE
Best practice for management of co-morbidities
Management of disorders of bone in immunoinflammatory disease:
do we need to do more?Session chair Socrates
PapapoulosFacultyEugene McCloskey Lorenz Hofbauer
New insights on the pathophysiology of inflammation-induced bone
disease
Effects of current therapeutics on BMD and fracture risk
Beyond inhibition of excess bone remodelling
Clinical care of vasculitisSession chair Ian BruceFacultyDavid
DCruz Stephen Hall
State-of-the-art in vasculitis management
Optimizing pharmacology in RA: what are the patient outcomes
beyond symptom control?Session chair Maxime DougadosFacultyMichael
Schiff Gerd Burmester Christopher D Buckley
Global perspectives: management of early RA optimized MTX and
early use of biologic therapy to improve long-term outcomes
Towards early arthritis management: a TEAM approach
It is with great pleasure that I warmly invite you to the Sixth
International Immunology Summit on Optimizing management of
musculoskeletal diseases: treating the human and the being.
We have witnessed extraordinary advances in the understanding of
musculoskeletal diseases over the past decade and a half, as well
as an increase in pharmacotherapeutic options. However, despite the
greatly improved outlook for patients with certain conditions, such
as rheumatoid arthritis and axial spondyloarthritis, very
significant unmet needs remain. While severe disability has
fortunately become less common, and more patients remain in
employment, they may still face difficulties that may not be
immediately apparent to their physicians, e.g. pain and fatigue.
We
must now look at the total burden of chronic disease in our
patients lives and how best we can optimize every aspect of their
quality of life.
Much of the therapeutic advance of recent years has focused on
improving immune dysregulation in the assumption that emotional,
mental and global health will improve correspondingly. Indeed,
while this is sometimes the case, there is often discordance
between improvements in objective measures of disease activity and
the patients own assessment of their wellbeing. It might be said
that optimizing pharmacotherapeutic intervention has focused on the
pathophysiological aspects of human disease. In English we refer to
our species as human beings, so there is another dimension to us
the being beyond the physiological alone, which determines how we
perceive and experience the world. Of course, these two aspects,
the human and the being are interdependent our feelings affect our
health and our health affects our perceptions and emotions.
The objective of the Summit is to discuss, share and learn how
we can adopt a more holistic approach to caring for our patients
beyond simply modifying disease activity, that is, how can we
aspire to optimize patient wellbeing? We have an exciting programme
and are fortunate in having a prestigious faculty to inspire and
help us on our journey. Discussions will encompass the spectrum of
rheumatic disease PsA, AxSpA, RA and SLE as well as disorders of
bone and the challenges of family planning and pregnancy in
autoimmune conditions. New this year is a state-of-the-art plenary
session on vasculitis. In addition to the plenaries, mini-symposia
sessions will explore and expand on the plenary topics and give
attendees the opportunity to meet with faculty and one another in
smaller groups.
Our intention is to foster an atmosphere of sharing and
participation through the use of interactive formats including
debates, panel discussions, case studies and hands-on workshops. We
will also harness the latest in multimedia technology to enhance
learning.
I look forward to welcoming you to Prague.
Professor Peter TaylorUniversity of Oxford, UK
Evolution to revolution: progress in the understanding and
management of AxSpA
Session chairDsire van der HeijdeFacultyMartin Rudwaleit Filip
van den Bosch Robert Landew Dominique Baeten
The importance of early, accurate diagnosis in AxSpA
Practical guidance on managing extra-articular features to
improve patients daily lives
Disease modification in AxSpA
Current management, and emerging pathways, treatment targets and
strategies
Virtual clinic: interactive case
How can we optimize management in PsA to further enhance
patients lives?
Session chairIain McInnesFacultyPeter Nash Wolf-Henning
Boehncke
Living with the dual burden of PsA: the patient viewpoint
Practical guidance on managing comorbidities in PsA wellbeing as
a therapeutic target
The future of PsA management emerging strategies and
therapies
Challenges in planning and managing pregnancy in autoimmune
diseaseSession chairDimitrios BoumpasFacultyCatherine
Nelson-Piercy
The patient-physician journey: what can we do for better
outcomes? Viewpoints from the patient, the obstetric physician and
the rheumatologist
Day and Summit Close
Session chairPeter Taylor
Programme may be subject to change
ProgrammeDear Colleagues and Friends
Inside left page 148 mm
Inside middle!48 mm
Inside right page (Folds in under left page) 146 mm
210mm
CIM14711214